BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 15515591)

  • 1. Pharmacokinetics of once-daily amikacin in healthy foals and therapeutic drug monitoring in hospitalized equine neonates.
    Bucki EP; Giguère S; Macpherson M; Davis R
    J Vet Intern Med; 2004; 18(5):728-33. PubMed ID: 15515591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation between pharmacokinetics of amikacin sulfate and sepsis score in clinically normal and hospitalized neonatal foals.
    Wichtel MG; Breuhaus BA; Aucoin D
    J Am Vet Med Assoc; 1992 May; 200(9):1339-43. PubMed ID: 1601717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum gentamicin concentrations in compromised neonatal foals.
    Raisis AL; Hodgson JL; Hodgson DR
    Equine Vet J; 1998 Jul; 30(4):324-8. PubMed ID: 9705116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of hypoxia and azotaemia on the pharmacokinetics of amikacin in neonatal foals.
    Green SL; Conlon PD; Mama K; Baird JD
    Equine Vet J; 1992 Nov; 24(6):475-9. PubMed ID: 1459063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacokinetics of amikacin in hypoxic premature foals.
    Green SL; Conlon PD
    Equine Vet J; 1993 Jul; 25(4):276-80. PubMed ID: 8354211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of a high dose of amikacin administered at extended intervals to neonatal foals.
    Magdesian KG; Wilson WD; Mihalyi J
    Am J Vet Res; 2004 Apr; 65(4):473-9. PubMed ID: 15077690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disposition of orally administered cefpodoxime proxetil in foals and adult horses and minimum inhibitory concentration of the drug against common bacterial pathogens of horses.
    Carrillo NA; Giguère S; Gronwall RR; Brown MP; Merritt KA; O'Kelley JJ
    Am J Vet Res; 2005 Jan; 66(1):30-5. PubMed ID: 15691032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in isolation rate and antimicrobial susceptibility of bacteria isolated from foals with sepsis at admission and after ≥48 hours of hospitalization.
    Theelen MJP; Wilson WD; Byrne BA; Edman JM; Kass PH; Mughini-Gras L; Magdesian KG
    J Vet Intern Med; 2020 Mar; 34(2):955-963. PubMed ID: 32022351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of amikacin in critically ill neonatal foals treated for presumed or confirmed sepsis.
    Adland-Davenport P; Brown MP; Robinson JD; Derendorf HC
    Equine Vet J; 1990 Jan; 22(1):18-22. PubMed ID: 2298186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma endotoxin concentrations in clinically normal and potentially septic equine neonates.
    Breuhaus BA; DeGraves FJ
    J Vet Intern Med; 1993; 7(5):296-302. PubMed ID: 8263848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of route of administration and age on the pharmacokinetics of amikacin administered by the intravenous and intraosseous routes to 3 and 5-day-old foals.
    Golenz MR; Wilson WD; Carlson GP; Craychee TJ; Mihalyi JE; Knox L
    Equine Vet J; 1994 Sep; 26(5):367-73. PubMed ID: 7988539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy and toxicity of two dosing-regimens of amikacin in neonates with sepsis.
    Abdel-Hady E; El Hamamsy M; Hedaya M; Awad H
    J Clin Pharm Ther; 2011 Feb; 36(1):45-52. PubMed ID: 21198719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of amikacin pharmacokinetics in a killer whale (Orcinus orca) and a beluga whale (Delphinapterus leucas).
    KuKanich B; Papich M; Huff D; Stoskopf M
    J Zoo Wildl Med; 2004 Jun; 35(2):179-84. PubMed ID: 15305513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and pharmacodynamics of enrofloxacin and a low dose of amikacin administered via regional intravenous limb perfusion in standing horses.
    Parra-Sanchez A; Lugo J; Boothe DM; Gaughan EM; Hanson RR; Duran S; Belknap JK
    Am J Vet Res; 2006 Oct; 67(10):1687-95. PubMed ID: 17014317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of a loading dose of amikacin in septic patients undergoing continuous renal replacement therapy.
    Taccone FS; de Backer D; Laterre PF; Spapen H; Dugernier T; Delattre I; Wallemacq P; Vincent JL; Jacobs F
    Int J Antimicrob Agents; 2011 Jun; 37(6):531-5. PubMed ID: 21489756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of intragastric administration of doxycycline: pharmacokinetics including body fluid, endometrial and minimum inhibitory concentrations.
    Bryant JE; Brown MP; Gronwall RR; Merritt KA
    Equine Vet J; 2000 May; 32(3):233-8. PubMed ID: 10836479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of a combination of amikacin sulfate and penicillin G sodium for intravenous regional limb perfusion in adult horses.
    Nieto JE; Trela J; Stanley SD; Yamout S; Snyder JR
    Can J Vet Res; 2016 Jul; 80(3):230-5. PubMed ID: 27408337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with survival of neonatal foals with bacteremia and racing performance of surviving Thoroughbreds: 423 cases (1982-2007).
    Sanchez LC; Giguère S; Lester GD
    J Am Vet Med Assoc; 2008 Nov; 233(9):1446-52. PubMed ID: 18980499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacteraemia in neonatal foals: clinicopathological differences between Gram-positive and Gram-negative infections, and single organism and mixed infections.
    Corley KT; Pearce G; Magdesian KG; Wilson WD
    Equine Vet J; 2007 Jan; 39(1):84-9. PubMed ID: 17228602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population pharmacokinetics of amikacin in patients with pediatric cystic fibrosis.
    Caceres Guido P; Perez M; Halac A; Ferrari M; Ibarra M; Licciardone N; Castaños C; Gravina LP; Jimenez C; Garcia Bournissen F; Schaiquevich P
    Pediatr Pulmonol; 2019 Nov; 54(11):1801-1810. PubMed ID: 31402602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.